1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging

Transcription

1 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Emerging Pharmaceutical Market - Indonesia and the Philippines -Introduction 3 Emerging Pharmaceutical Market - Indonesia and the Philippines Industry Characterstics 3.1 Market Size and Market Forecast Indonesia The Philippines 3.2 Market Share by Therapeutic Area Indonesia The Philippines 3.3 Market Share Branded versus Generic Market Share Indonesia The Philippines 3.4 Top Five Pharmaceutical Companies, Market Share Indonesia The Philippines 3.5 R&D Expenditure and Innovations Indonesia The Philippines 3.6 Trends and Recent Developments in Foreign Direct Investment Indonesia The Philippines 3.7 Marketing Distribution Channel Indonesia The Philippines 3.8 PESTLE Analysis Indonesia The Philippines 4 Emerging Pharmaceutical Market - Indonesia and the Philippines Macroeconomic Environment 4.1 Demographic Analysis Population Size, Growth, and Structure Mortality Rate Population Ageing and Health 4.2 GDP Indonesia The Philippines 4.3 Per Capita Income Indonesia The Philippines 4.4 Income Status Indonesia The Philippines 4.5 Healthcare Expenditure

2 4.5.1 Context 4.6 Healthcare Infrastructure Context Analytical Framework 5 Emerging Pharmaceutical Market - Indonesia and The Philippines Healthcare Regulation 5.1 Pharmaceutical Regulation in Indonesia and the Philippines Healthcare System Structure 5.2 Drug Approval Process Indonesia The Philippines 5.3 Patents and Generics (IPR) Context Analytical Framework 5.4 Health Insurance Coverage Indonesia The Philippines 5.5 Clinical Trials Context Analytical Framework 5.6 Pricing and Reimbursement Context 6 Emerging Pharmaceutical Market - Indonesia and the Philippines Industry Trends 6.1 Deals by Type Indonesia The Philippines 6.2 Mergers and Acquisitions Deals by Year Deal by Value Indonesia and the Philippines Top Five M&A Deals 6.3 Licensing Agreements Deals by Year Deals by Value Indonesia and the Philippines Top Five Licensing Deals 6.4 Co-Development Deals By Year By Value Indonesia and the Philippines Top Five Co-Development Deals 7 Emerging Pharmaceutical Market - Indonesia and The Philippines Service Industries CMO, CRO 7.1 Clinical Research Organization (CRO) Indonesia CRO PEST Analysis Philippines CRO PEST Analysis 7.2 Contract Manufacturing Organization (CMO) Indonesia CMO PEST Analysis The Philippines CMO PEST Analysis

3 8 Appendix 8.1 Market Definitions 8.2 Abbreviations 8.3 Sources 8.4 Research Methodology Industry Characteristics Demographic Analysis Healthcare Regulation Industry Trends Service Industries CMO, CRO 8.5 Contact Us 8.6 Disclaimer 1.1 List of Tables Table 1: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Pharmaceutical Market Size ($bn), Table 2: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Pharmaceutical Market Size ($bn), Table 3: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Pharmaceutical Market Size ($bn), Table 4: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Pharmaceutical Market Size ($bn), Table 5: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Demographic Analysis, Population Size, January 2011 Table 6: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Demographic Analysis, Growth Rate (%), Table 7: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Age Structure (%), Table 8: Emerging Pharmaceutical Market, The Philippines, Macroeconomic Environment, Demographic Analysis, Growth Rate (%), Table 9: Emerging Pharmaceutical Market: Indonesia and The Philippines, Macroeconomic Environment, Mortality Rate Analysis (deaths/1,000 population), January 2011 Table 10: Emerging Pharmaceutical Market, Indonesia, Macroeconomic Environment, Age Structure, 2010 Table 11: Emerging Pharmaceutical Market, The Philippines, Macroeconomic Environment, Age Structure, 2010 Table 12: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, GDP Growth (Annual %), Table 13: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Health Expenditure, Total (% of GDP), Table 14: Emerging Pharmaceutical Market: The Philippines, Macroeconomic Environment, GDP Growth (Annual %), Table 15: Emerging Pharmaceutical Market: The Philippines, Macroeconomic Environment, Health Expenditure, Total (% of GDP), Table 16: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, GDP per capita (PPP), $,

4 Table 17: Emerging Pharmaceutical Market: The Philippines, Macroeconomic Environment, GDP per capita (PPP), $, Table 18: Emerging Pharmaceutical Market, Indonesia, Macroeconomic Environment, Income Status, 2010 Table 19: Emerging Pharmaceutical Market, The Philippines, Macroeconomic Environment, Income Status, 2010 Table 20: Emerging Pharmaceutical Market, Indonesia, Healthcare Regulation, Number of Clinical Trials, Table 21: Emerging Pharmaceutical Market, The Philippines, Healthcare Regulation, Number of Clinical Trials, Table 22: Emerging Pharmaceutical Market, Healthcare Regulation, Total Number of Clinical Trials Until 2012 Table 23: Emerging Pharmaceutical Market, The Philippines, Healthcare Regulation, Drug Pricing, Table 24: Emerging Pharmaceutical Market: Indonesia, Industry Trends, Deals by Type, Table 25: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Deals by Type, Table 26: Emerging Pharmaceutical Market, Indonesia, Industry Trends, M&A Deals by Year, Table 27: Emerging Pharmaceutical Market, The Philippines, Industry Trends, M&A Table 28: Emerging Pharmaceutical Market, Indonesia, Industry Trends, M&A Deals by Value, Table 29: Emerging Pharmaceutical Market, The Philippines, Industry Trends, M&A Table 30: Emerging Pharmaceutical Market: Indonesia and the Philippines, Industry Trends, Top Five M&A Deals by Value, Table 31: Emerging Pharmaceutical Market: Indonesia, Industry Trends, Licensing Deals by Year, Table 32: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Licensing Table 33: Emerging Pharmaceutical Market: Indonesia, Industry Trends, Licensing Deals by Value, Table 34: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Licensing Deals by Value, Table 35: Emerging Pharmaceutical Market: Indonesia and the Philippines, Industry Trends, Top Five Licensing Deals by Value, Table 36: Emerging Pharmaceutical Market, Indonesia, Industry Trends, Co- Development Table 37: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Co- Development Table 38: Emerging Pharmaceutical Market, Indonesia, Industry Trends, Co- Development Deals by Value, Table 39: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Co- Development Deals by Value,

5 Table 40: Emerging Pharmaceutical Market: Indonesia and The Philippines, Industry Trends, Top Five Co-Development Deals by Value, List of Figures Figure 1: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Pharmaceutical Market Size ($bn), Figure 2: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Pharmaceutical Market Size ($bn), Figure 3: Emerging Pharmaceutical Market, Industry Characteristics, Patient Population, 2009, 2010 Figure 4: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Market Segmentation by Therapeutic Class (%), 2010 Figure 5: Emerging Pharmaceutical Market, The Philippines, Industry Characteristics, Prevalence of Non-Communicable Diseases (%), 2010 Figure 6: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Branded and Generic Drugs Market Share (%), 2010 Figure 7: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, OTC and Prescription Drugs Market Share (%), 2010 Figure 8: Emerging Pharmaceutical Market, The Philippines, Industry Characteristics, OTC and Prescription Drugs Market Share (%), 2010 Figure 9: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Top Five Pharmaceutical Companies Market Share (%), 2010 Figure 10: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, PT. Kalbe Farma Tbk SWOT Analysis, 2010 Figure 11: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Dexa Medica SWOT Analysis, 2010 Figure 12: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Sanbe Farma SWOT Analysis, 2010 Figure 13: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, PT. SOHO Industri Pharmasi SWOT Analysis, 2010 Figure 14: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, PT Tempo Scan Pacific Tbk. SWOT Analysis, 2010 Figure 15: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Top Five Pharmaceutical Companies Market Share (%), 2010 Figure 16: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Unilab SWOT Analysis, 2010 Figure 17: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, GSK SWOT Analysis, 2010 Figure 18: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Euro-Med Lab SWOT Analysis, 2010 Figure 19: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Pfizer Inc SWOT Analysis, 2010 Figure 20: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Bristol Myers Squibb SWOT Analysis, 2010 Figure 21: Emerging Pharmaceutical Market: Indonesia, Industry Characteristics, Marketing Distribution Channel (%), 2008

6 Figure 22: Emerging Pharmaceutical Market: The Philippines, Industry Characteristics, Marketing Distribution Channel (%), 2008 Figure 23: Emerging Pharmaceutical Market, Indonesia, Industry Characteristics, Indonesia Pharmaceutical Market PESTLE Analysis, 2010 Figure 24: Emerging Pharmaceutical Market, The Philippines, Industry Characteristics, The Philippines Pharmaceutical Market PESTLE Analysis, 2010 Figure 25: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Demographic Analysis, Growth Rate (%), Figure 26: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Age Structure (%), Figure 27: Emerging Pharmaceutical Market, The Philippines, Macroeconomic Environment, Demographic Analysis, Growth Rate (%), Figure 28: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, GDP Growth (Annual %), Figure 29: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Health Expenditure, Total (% of GDP), Figure 30: Emerging Pharmaceutical Market: The Philippines, Macroeconomic Environment, GDP Growth (Annual %), Figure 31: Emerging Pharmaceutical Market: The Philippines, Macroeconomic Environment, Health Expenditure, Total (% of GDP), Figure 32: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, GDP per capita (PPP), $, Figure 33: Emerging Pharmaceutical Market: The Philippines, Macroeconomic Environment, GDP per capita (PPP), $, Figure 34: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Healthcare Expenditure ($), 2008 Figure 35: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Healthcare Infrastructure, 2009 Figure 36: Emerging Pharmaceutical Market: Indonesia, Macroeconomic Environment, Healthcare Infrastructure, Number of Hospitals, Figure 37: Emerging Pharmaceutical Market: The Philippines, Macroeconomic Environment, Healthcare Infrastructure, Number of Hospitals, Figure 38: Emerging Pharmaceutical Market: Indonesia, Healthcare Regulation, Organizational Structure of the Public Healthcare System, 2010 Figure 39: Emerging Pharmaceutical Market: The Philippines, Healthcare Regulation, Healthcare Flow-of-Funds, 2010 Figure 40: Emerging Pharmaceutical Market, Indonesia, Healthcare Regulation, Drug Approval Process, 2010 Figure 41: Emerging Pharmaceutical Market, Healthcare Regulation, IPR, Counterfeit Incident Trends by Region, 2010 Figure 42: Emerging Pharmaceutical Market, Indonesia, Healthcare Regulation, Health Insurance Coverage, 2008 Figure 43: Emerging Pharmaceutical Market, The Philippines, Healthcare Regulation, Health Insurance Coverage, 2010 Figure 44: Emerging Pharmaceutical Market: Indonesia, Industry Trends, Deals by Type (%),

7 Figure 45: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Deals by Type (%), Figure 46: Emerging Pharmaceutical Market, Indonesia, Industry Trends, M&A Deals by Year, Figure 47: Emerging Pharmaceutical Market, The Philippines, Industry Trends, M&A Figure 48: Emerging Pharmaceutical Market, Indonesia, Industry Trends, M&A Deals by Value (%), Figure 49: Emerging Pharmaceutical Market, The Philippines, Industry Trends, M&A Deals by Year (%), Figure 50: Emerging Pharmaceutical Market: Indonesia, Industry Trends, Licensing Figure 51: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Licensing Figure 52: Emerging Pharmaceutical Market: Indonesia, Industry Trends, Licensing Deals by Value (%), Figure 53: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Licensing Deals by Value (%), Figure 54: Emerging Pharmaceutical Market, Indonesia, Industry Trends, Co- Development Figure 55: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Co- Development Figure 56: Emerging Pharmaceutical Market, Indonesia, Industry Trends, Co- Development Deals by Value (%), Figure 57: Emerging Pharmaceutical Market, The Philippines, Industry Trends, Co- Development Deals by Value (%), Figure 58: Emerging Pharmaceutical Market, Indonesia, Service Industry, Emerging Markets CRO Analysis, 2010 Figure 59: Emerging Pharmaceutical Market, Indonesia, Service Industry, CRO Market PEST Analysis, 2010 Figure 60: Emerging Pharmaceutical Market, The Philippines, Service Industry, CRO Market PEST Analysis, 2010 Figure 61: Emerging Pharmaceutical Market, Indonesia, Service Industry, CMO Market PEST Analysis, 2010 Figure 62: Emerging Pharmaceutical Market, The Philippines, Service Industry, CMO Market PEST Analysis, 2010